Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Kang, Minyong ^a   Jeong, Chang Wook ^a   Ku, Ja Hyeon ^a   Kwak, Choel ^a   Kim, Hyeon Hoe ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; DIET RESTRICTION; DISEASE ASSOCIATION; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIAGNOSIS; KAPLAN MEIER METHOD; NONPARAMETRIC TEST; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; TUMOR RECURRENCE;

BIOMARKERS, TUMOR; HUMANS; HYPERTRIGLYCERIDEMIA; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 84925590056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122438     Document Type: Article

References (27)

1. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007; 10: 763-777. PMID: 17882277
2. Tete S, Nicoletti M, Saggini A, Maccauro G, Rosati M, Conti F, et al. Nutrition and cancer prevention. Int J Immunopathol Pharmacol. 2012; 25:573-581. PMID: 23058007
3. Gerber M. Background review paper on total fat, fatty acid intake and cancers. Ann Nutr Metab. 2009; 55:140-161. doi: 10.1159/000229000 PMID: 19752540
4. Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, et al. Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2009; 18:2807-2813. doi: 10.1158/1055-9965.EPI-09-0472 PMID: 19887582
5. Mondul AM, Weinstein SJ, Virtamo J, Albanes D. Serum total and HDL cholesterol and risk of prostate cancer. Cancer Causes Control. 2011; 22:1545-1552. doi: 10.1007/s10552-011-9831-7 PMID: 21915616
6. Jacobs EJ, Stevens VL, Newton CC, Gapstur SM. Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Causes Control. 2012; 23:1289-1296. doi: 10.1007/s10552-012-0006-y PMID: 22692409
7. His M, Zelek L, Deschasaux M, Pouchieu C, Kesse-Guyot E, Hercberg S, et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol. 2014; 29:119-132. doi: 10.1007/s10654-014-9884-5 PMID: 24519551
8. Chandra A, Rohatgi A. The Role of Advanced Lipid Testing in the Prediction of Cardiovascular Disease. Curr Atheroscler Rep. 2014; 16:394. doi: 10.1007/s11883-013-0394-9 PMID: 24445969
9. Mondul AM, Clipp SL, Helzlsouer KJ, Platz EA. Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control. 2010; 21:61-68. doi: 10.1007/s10552-009-9434-8 PMID: 19806465
10. Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, et al. Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database. Cancer Epidemiol Biomarkers Prev. 2014; 23:2349-2356 doi: 10.1158/1055-9965.EPI-14-0458 PMID: 25304929
11. Platz EA, Clinton SK, Giovannucci E. Association between plasma cholesterol and prostate cancer in the PSA era. Int J Cancer. 2008; 123:1693-1698. doi: 10.1002/ijc.23715 PMID: 18646186
12. Huxley R. Asia Pacific Cohort Studies Collaboration. The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region. Asian Pac J Cancer Prev. 2007; 8: 199-205. PMID: 17696731
13. Diffenderfer MR, Schaefer EJ. The composition and metabolism of large and small LDL. Curr Opin Lipidol. 2014; 25:221-226. doi: 10.1097/MOL.0000000000000067 PMID: 24811298
14. National Cholesterol Education Program Expert Panel on Detection E and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106:3143-3421. PMID: 12485966
15. Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest. 2005; 115:959-968. PMID: 15776112
16. Llaverias G, Danilo C, Wang Y, Witkiewicz AK, Daumer K, Lisanti MP, et al. A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer. Am J Pathol. 2010; 177:3180-3191. doi: 10.2353/ajpath.2010.100568 PMID: 21088217
17. Kok DE, van Roermund JG, Aben KK, den Heijer M, Swinkels DW, Kampman E, et al. Blood lipid levels and prostate cancer risk; a cohort study. Prostate Cancer Prostatic Dis. 2011; 14:340-345. doi: 10.1038/pcan.2011.30 PMID: 21727905
18. Kotani K, Sekine Y, Ishikawa S, Ikpot IZ, Suzuki K, Remaley AT. High-density lipoprotein and prostate cancer: an overview. J Epidemiol. 2013; 23:313-319. PMID: 23985823
19. Magura L, Blanchard R, Hope B, Beal JR, Schwartz GG, Sahmoun AE. Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes Control. 2008; 19:1259-1266. doi: 10.1007/s10552-008-9197-7 PMID: 18704722
20. Kitahara CM, Berrington de Gonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011; 29:1592-1598. doi: 10.1200/JCO.2010.31.5200 PMID: 21422422
21. Hayashi N, Matsushima M, Yamamoto T, Sasaki H, Takahashi H, Egawa S. The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years. BJU Int. 2012; 109:515-519. doi: 10.1111/j.1464-410X.2011.10358.x PMID: 21812901
22. Griebling TL. Re: The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥ 60 years. J Urol. 2012; 187:1270-1271. doi: 10.1016/j.juro.2011.12.086 PMID: 22423914
23. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674 doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
24. Pelton K, Freeman MR, Solomon KR. Cholesterol and prostate cancer. Curr Opin Pharmacol. 2012; 12:751-759. doi: 10.1016/j.coph.2012.07.006 PMID: 22824430
25. Solomon KR, Freeman MR. The Complex Interplay Between Cholesterol and Prostate Malignancy. Urol Clin North Am. 2011; 38:243-259. doi: 10.1016/j.ucl.2011.04.001 PMID: 21798387
26. de Martino M, Leitner CV, Seemann C, Hofbauer SL, Lucca I, Haitel A, et al. Preoperative serum cholesterol is and in independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int. 2015; 115:397-404. doi: 10.1111/bju.12767 PMID: 24698164
27. Ko K, Park YH, Lee JW, Ku JH, Kwak C, Kim HH. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC). BJU Int. 2013; 112:775-780. doi: 10.1111/bju.12275 PMID: 24028765